Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of sintilimab (a PD-1 inhibitor) in combination with metformin for small-cell lung can…
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) [Phase 3]
Phase 3 trial evaluating carboplatin/etoposide with or without atezolizumab in untreated extensive-stage small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) [Phase 2]
A phase 2 clinical trial update for anlotinib in small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy [Phase 1, Phase 2]
A Phase 1b/2 study of tarextumab (OMP-59R5) in combination with etoposide and platinum therapy in Stage IV small cell lung cancer was termin…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial investigating temozolomide for preventing brain metastases in small cell lung cancer is reported as ongoing with un…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride [Phase 4]
Phase 4 clinical trial investigating first-line treatment of small cell lung cancer with anlotinib hydrochloride.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers [Phase 3]
Phase 3 trial evaluating early palliative care added to standard care versus standard care alone in patients with incurable lung or non-colo…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients [Phase 1]
A Phase 1 clinical trial evaluating chloroquine as an anti-autophagy agent in stage IV small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating cisplatin and etoposide with or without veliparib in extensive-stage small cell lung cancer has completed recru…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Bioinformation Therapy for Lung Cancer [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 trial of a bioinformation therapy for small-cell lung cancer, with the study status listed as completed.
-
CLINICAL_TRIALS research · 2019-01-22Clinical Trial Update: Molecular Profiling in Small Cell Lung Cancer
Clinical trial update on molecular profiling in small cell lung cancer, sponsored by Zhujiang Hospital; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer [Phase 2]
Phase 2 trial investigating SHR-1210 in combination with epirubicin for extensive-stage small cell lung cancer is reported as ongoing with s…
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: A Study of LY2940680 in Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of LY2940680 in small cell lung carcinoma was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial comparing belotecan to topotecan as monotherapy in sensitive-relapsed small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) [Phase 2]
Phase 2 study evaluating alisertib plus paclitaxel vs placebo plus paclitaxel as second-line therapy for small cell lung cancer has complete…
-
CLINICAL_TRIALS withdrawal · 2018-12-26Clinical Trial Update: Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating safety of rovalpituzumab tesirine for third-line and later relapsed/refractory small cell lung cancer has been with…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC [Phase 2]
Phase 2 trial update on the efficacy and safety of anlotinib as maintenance therapy after first-line chemotherapy in small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC [Phase 2]
Phase 2 randomized study evaluating maintenance therapy with MGN1703 in small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Anlotinib in Treatment of Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating anlotinib for recurrent small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial of carboplatin and etoposide with vorinostat in extensive-stage small cell lung cancer has been terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating mesylate apatinib combined with irinotecan for recurrent small cell lung cancer is in progress, with sta…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer [Phase 2]
Phase 2 trial update reports safety and efficacy results for SNS-595 in patients with advanced small cell lung cancer. The results summarize…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Sunitinib Malate in Treating Patients With Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib malate for small cell lung cancer has been terminated.
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. [Phase 2]
An update on a Phase 2 trial evaluating NK cell-based immunotherapy as maintenance therapy for small cell lung cancer, with the current tria…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer [Phase 1, Phase 2]
Clinical trial update for rovalpituzumab tesirine (SC16LD6.5) in recurrent small cell lung cancer across Phase 1 and Phase 2, with results p…